GBA1 and Parkinson disease: It is also found that the frequency of glucocerebrosidase mutations is increased in postmortem samples from PD patients who had positive α-synuclein inclusions [56, 57], and the BDNF (Met/Met) homozygotes demonstrate dramatically worse cognitive impairment in PD patients compared to noncarriers [58].